...
首页> 外文期刊>Bangladesh Journal of Medical Science >Coagulation Disturbance among Essential Hypertensive and Diabetes Mellitus Type II Patients - Khartoum State
【24h】

Coagulation Disturbance among Essential Hypertensive and Diabetes Mellitus Type II Patients - Khartoum State

机译:高血压和二型糖尿病患者的凝血功能障碍-喀土穆州

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: This was a descriptive study conducted in Khartoum. The aim was to compare the prothrombin time, activated partial thromboplastin time and fibrinogen level between type II diabetic patients, hypertensive patient, patients had both diseases and control.Materials and Methods: Analytical experimental study was done in Khartoum state, Sudan, during the period of March 2014 to April 2014 to measure coagulation disturbance among essential hypertensive and diabetes mellitus type II patients. The study included 120 consecutive persons were enrolled; 30 had diabetes type II, 30 had diabetes mellitus type II plus hypertension, 30 had hypertension against 30 healthy individual setting as control.Results: The result found that prothrombin time (PT) was significantly increased in diabetic type II and hypertensive patients compared with control (p-value0.05). While, it was significantly decreased in patients with diabetes type II with hypertension compared to who had only hypertension or only diabetes, activated partial thromboplastin time (APTT) was significantly increased in diabetic type II and among patients with both diseases compared with control (p-value0.05) but it was significantly increased in patients with both diseases compared to who had only hypertension or only diabetes. Fibrinogen level was significantly increased in diabetic type II and patients with both diseases compared to control (p-value 0.05) and significantly increase in patients with both diseases compared to who had only hypertension or only diabetes.Conclusion: Our results was concluded a significant correlation between PT and duration of diseased in patients with both diseases (p-value 0.001). In conclusion, fibrinogen was significantly increased in patients with diabetes plus hypertension compared to patients with hypertension or patients with diabetes type II.Bangladesh Journal of Medical Science Vol.15(3) 2016 p.424-429
机译:背景:这是在喀土穆进行的描述性研究。目的是比较II型糖尿病患者,高血压患者,既有疾病又有控制的患者的凝血酶原时间,活化的部分凝血活酶时间和纤维蛋白原水平。材料与方法:在此期间,在苏丹喀土穆州进行了分析实验研究(2014年3月至2014年4月),以测量原发性高血压和II型糖尿病患者的凝血功能紊乱。该研究包括120名连续的研究对象。 II型糖尿病30例,II型糖尿病30例,高血压30例,以30名健康个体为对照组。结果:结果发现,与对照组相比,II型糖尿病和高血压患者的凝血酶原时间(PT)显着增加(p值0.05)。尽管与仅患有高血压或仅患有糖尿病的II型糖尿病合并高血压患者相比,该比例显着降低,但与对照组相比,II型糖尿病患者以及两种疾病患者中活化部分凝血活酶时间(APTT)均显着增加(p-值0.05),但与仅患有高血压或仅患有糖尿病的两种疾病相比,这两种疾病的患者均显着增加。与对照组相比,II型糖尿病患者和两种疾病患者的纤维蛋白原水平均显着升高(p值0.05),与仅患有高血压或仅糖尿病的患者相比,两种疾病患者的纤维蛋白原水平均显着升高。两种疾病患者的PT和患病时间之间的相关性(p值0.001)。总之,与高血压患者或II型糖尿病患者相比,糖尿病加高血压患者的纤维蛋白原显着增加。孟加拉国医学杂志Vol.15(3)2016 p.424-429

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号